Get notified when CL files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: CL COLGATE PALMOLIVE CO 10-Q

Colgate-Palmolive Q3 sales rise 4.6% to $5.37B; net income up 2.2% to $751M

Filed October 30, 2026 · Period ending September 30, 2026 · Compared to 10-Q Oct 31, 2025 · ~1 min read

Key Changes

  • high

    Worldwide net sales grew 4.6% to $5.37B in Q3 2026, driven by volume growth of 1.7% and pricing of 2.0%.

    MD&A: Net Sales verify on EDGAR →
  • high

    Gross margin improved 80 basis points to 60.2%, reversing last year's decline, on cost savings and pricing.

    MD&A: Gross Margin verify on EDGAR →
  • high

    Restructuring charges of $30M in Q3 and $333M year-to-date reflect an expanded Strategic Growth and Productivity Program with cumulative pre-tax charges now estimated at $350–$550M.

    MD&A: Restructuring verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.

Partner

Trade CL commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Nov 2, 2026 · How we verify